This is an old revision of this page, as edited by UnitedStatesian (talk | contribs) at 22:41, 9 February 2020 (→External links: use finance links template). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Pharmacopeia, Inc." – news · newspapers · books · scholar · JSTOR (September 2011) (Learn how and when to remove this message) |
Pharmacopeia was a public biotechnology company that pioneered the field of small molecule combinatorial chemistry.
Pharmacopeia was founded by Larry Bock and Drs. Michael Wigler, Clark Still and Jack Chabala.
Pharmacopeia went public in 1996 and was acquired by Ligand Pharmaceuticals on December 13, 2008.
